Last reviewed · How we verify

"A Prospective, Randomized, Comparative Clinical Trial of the Efficacy and Safety of Levofloxacin Versus Isoniazid in the Treatment of Latent Tuberculosis Infection in Liver Transplant Patients". (FLISH-ILT)

NCT01761201 Phase 3 TERMINATED

A multicenter, prospective, non-inferiority, randomized and open clinical trial comparing levofloxacin with isoniazid in the treatment of latent tuberculosis infection in patients eligible for liver transplantation. Patients over 18 years of age on the waiting list for liver transplantation. Sample size: n=870 patients. HYPOTHESIS Levofloxacin treatment of latent tuberculosis infection, begun while on the waiting list for liver transplantation, is safer and not less effective than isoniazid treatment begun after transplantation when liver function is stable.

Details

Lead sponsorFundación Pública Andaluza para la gestión de la Investigación en Sevilla
PhasePhase 3
StatusTERMINATED
Enrolment68
Start date2012-01
Completion2014-02

Conditions

Interventions

Primary outcomes

Countries

Spain